University of Washington | United States
Dr. Taeyoon Jung is a medicinal chemist and trained pharmacist with strong expertise in drug metabolism and pharmacokinetics (DMPK), integrating experimental and computational approaches to advance drug discovery and safety evaluation. He earned his PhD in Medicinal Chemistry from the University of Washington, following an MS in Drug Evaluation and a PharmD from Chungnam National University. His academic and professional experience spans leading research universities and industry, including graduate research roles in medicinal chemistry, pharmacology, and molecular toxicology, as well as a DMPK graduate internship in a global biopharmaceutical company. Dr. Jung’s research focuses on hydrogen sulfide signaling in cardiac and hepatic stress models, species-dependent drug metabolism, toxicology of bioactivated metabolites, and structure–function relationships of metabolic enzymes. He is highly skilled in LC-MS/MS-based metabolite quantification, in vitro ADME systems, cell-based and molecular assays, and advanced computational modeling such as molecular docking, molecular dynamics, and metadynamics for inhibitor design. His work has contributed to multiple peer-reviewed publications in drug metabolism and toxicology. In recognition of his scientific excellence, he has received several competitive scholarships, endowed funds, and presentation awards. Overall, Dr. Jung’s interdisciplinary background bridges chemistry, pharmacology, and computation, positioning him as a versatile researcher dedicated to improving drug safety and therapeutic development.
View ORCID Profile
Featured Publications